Bagherpoor, A.J.; Kučírek, M.; Fedr, R.; Sani, S.A.; Štros, M.
Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide. Biomolecules 2020, 10, 1450.
https://doi.org/10.3390/biom10101450
AMA Style
Bagherpoor AJ, Kučírek M, Fedr R, Sani SA, Štros M.
Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide. Biomolecules. 2020; 10(10):1450.
https://doi.org/10.3390/biom10101450
Chicago/Turabian Style
Bagherpoor, Alireza Jian, Martin Kučírek, Radek Fedr, Soodabeh Abbasi Sani, and Michal Štros.
2020. "Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide" Biomolecules 10, no. 10: 1450.
https://doi.org/10.3390/biom10101450
APA Style
Bagherpoor, A. J., Kučírek, M., Fedr, R., Sani, S. A., & Štros, M.
(2020). Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide. Biomolecules, 10(10), 1450.
https://doi.org/10.3390/biom10101450